XML 19 R6.htm IDEA: XBRL DOCUMENT v3.25.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (1,471,000) $ (1,564,000)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 1,663,000 1,168,000
Loss on disposal or impairment of long-lived assets 56,000 4,000
Loss on extinguishment of debt 300,000  
Stock-based compensation expense 2,412,000 1,858,000
Amortization of deferred commissions 17,000 16,000
Amortization of debt discount and issuance costs 48,000 47,000
Amortization of right-of-use assets 87,000 137,000
Change in value of contingent consideration (1,310,000) (12,000)
Provision for accounts receivable 289,000 111,000
Changes in operating assets and liabilities:    
Accounts receivable (1,360,000) (703,000)
Prepaid expenses and other assets (330,000) (372,000)
Accounts payable and accruals 285,000 (447,000)
Operating lease liability (98,000) (199,000)
Deferred revenue 583,000 569,000
Net cash provided by operating activities 1,171,000 613,000
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of equipment (23,000) (75,000)
Software development costs (978,000) (947,000)
Patent costs (4,000) (13,000)
Payment for acquisition (1,666,000)  
Net cash used in investing activities (2,671,000) (1,035,000)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from term loan, net of lender fees 13,351,000  
Payments for costs directly attributable to the issuance of term loan (356,000)  
Repayment of term loan (7,000,000)  
Payments for debt extinguishment costs (249,000)  
Proceeds from exercise of options 38,000  
Payments related to settlement of employee shared-based awards (1,340,000) (744,000)
Repurchase of common stock (1,765,000) (2,016,000)
Repayments of finance leases   (7,000)
Settlement of contingent consideration   (1,677,000)
Proceeds from employee stock purchase plan 39,000 53,000
Proceeds from common stock offering, net of transaction costs   663,000
Net cash provided by (used in) financing activities 2,718,000 (3,728,000)
Net increase (decrease) in cash and cash equivalents 1,218,000 (4,150,000)
Cash and cash equivalents -beginning of period 5,651,000 9,236,000
Cash and cash equivalents - end of period $ 6,869,000 $ 5,086,000